
DocsApp, whose investors include DeNA and Techmatrix, has joined forces with MediBuddy in deal buoyed by a $20m round backed by Mitsui Sumitomo.
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
The classified listings group is putting up about $46m for Info Edge Venture Fund and expects to mobilise external backers to hit a $100m target.
Medical consultation platform developer Ubie has received $18.4m from medicine distributor Suzuken that will be used to enhance its apps, increase headcount and expand internationally.
Novartis bought $10m in shares as the fibrosis treatment developer floated at the top of its range in an expanded initial public offering.
NodThera, a developer of treatments for conditions caused by chronic inflammation, has completed a Novo Ventures-led round that also featured Sanofi Ventures.
Pfizer Breakthrough Growth Initiative is set to allocate as much as $500m to publicly listed clinical-stage life science technology developers.
MassMutual Ventures now has $450m under management across five funds, with its third main fund to invest in North America, Europe and Israel.
Bigfoot Medical, which is developing smart pens for diabetes management, closed an Abbott-led series C round after securing $45m in the first tranche in January.
Fosun and Varian Medical Systems returned to help medical imaging platform developer Arterys increase its total funding to $70m.